IL66890A - 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepines,their manufacture and pharmaceutical compositions containing them - Google Patents

7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepines,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL66890A
IL66890A IL66890A IL6689082A IL66890A IL 66890 A IL66890 A IL 66890A IL 66890 A IL66890 A IL 66890A IL 6689082 A IL6689082 A IL 6689082A IL 66890 A IL66890 A IL 66890A
Authority
IL
Israel
Prior art keywords
halophenyl
benzodiazepines
dihydro
bromo
manufacture
Prior art date
Application number
IL66890A
Other languages
English (en)
Other versions
IL66890A0 (en
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of IL66890A0 publication Critical patent/IL66890A0/xx
Publication of IL66890A publication Critical patent/IL66890A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL66890A 1981-09-30 1982-09-29 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepines,their manufacture and pharmaceutical compositions containing them IL66890A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813138769 DE3138769A1 (de) 1981-09-30 1981-09-30 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
IL66890A0 IL66890A0 (en) 1982-12-31
IL66890A true IL66890A (en) 1985-11-29

Family

ID=6142952

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66890A IL66890A (en) 1981-09-30 1982-09-29 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepines,their manufacture and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4505908A (xx)
EP (1) EP0075855B1 (xx)
JP (1) JPS5867678A (xx)
AT (1) ATE17123T1 (xx)
AU (1) AU553689B2 (xx)
CA (1) CA1196635A (xx)
DD (1) DD203907A5 (xx)
DE (2) DE3138769A1 (xx)
DK (1) DK156065C (xx)
ES (1) ES515774A0 (xx)
FI (1) FI68047C (xx)
GR (1) GR77652B (xx)
HU (1) HU189179B (xx)
IE (1) IE53937B1 (xx)
IL (1) IL66890A (xx)
NO (1) NO157698C (xx)
NZ (1) NZ202036A (xx)
PH (1) PH18102A (xx)
PT (1) PT75553B (xx)
ZA (1) ZA827140B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221402A1 (de) * 1982-06-05 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
US6818607B1 (en) 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
JP2003508587A (ja) 1999-08-27 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 安定性増強配合成分、これを用いた組成物および洗濯方法
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
MXPA02002125A (es) * 1999-08-27 2002-09-18 Procter & Gamble Componentes aumentadores del blanqueado, composiciones y metodos de lavanderia.
AU7072200A (en) * 1999-08-27 2001-03-26 Procter & Gamble Company, The Fast-acting formulation components, compositions and laundry methods employing same
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
US20130325104A1 (en) 2006-05-26 2013-12-05 Abbott Cardiovascular Systems Inc. Stents With Radiopaque Markers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265371C3 (de) * 1972-05-03 1980-12-11 Kali-Chemie Ag, 3000 Hannover N-(3-Benzoylaminopropyl)-aniline
US4244869A (en) * 1972-05-03 1981-01-13 Kali-Chemie A.G. Benzodiazepine derivatives and process of making them
DE2520937C3 (de) * 1975-05-10 1978-10-12 Kali-Chemie Ag, 3000 Hannover 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
HU189179B (en) 1986-06-30
EP0075855A2 (de) 1983-04-06
FI823338A0 (fi) 1982-09-29
EP0075855B1 (de) 1985-12-27
ZA827140B (en) 1983-07-27
NO157698B (no) 1988-01-25
AU553689B2 (en) 1986-07-24
IE53937B1 (en) 1989-04-26
GR77652B (xx) 1984-09-25
DE3138769A1 (de) 1983-04-14
DD203907A5 (de) 1983-11-09
PT75553B (en) 1984-12-12
EP0075855A3 (en) 1983-06-15
FI823338L (fi) 1983-03-31
NZ202036A (en) 1985-02-28
US4505908A (en) 1985-03-19
DK156065B (da) 1989-06-19
PH18102A (en) 1985-03-20
NO157698C (no) 1988-05-04
ATE17123T1 (de) 1986-01-15
DK156065C (da) 1989-11-13
JPS5867678A (ja) 1983-04-22
ES8306126A1 (es) 1983-05-01
NO823265L (no) 1983-04-05
CA1196635A (en) 1985-11-12
IL66890A0 (en) 1982-12-31
ES515774A0 (es) 1983-05-01
AU8883882A (en) 1983-04-14
FI68047C (fi) 1985-07-10
DK431782A (da) 1983-03-31
JPH0433791B2 (xx) 1992-06-04
PT75553A (en) 1982-10-01
DE3268156D1 (en) 1986-02-06
FI68047B (fi) 1985-03-29
IE822362L (en) 1983-03-30

Similar Documents

Publication Publication Date Title
IL66890A (en) 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepines,their manufacture and pharmaceutical compositions containing them
DE3576075D1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
DE58907706D1 (de) 4,5,7,8-Tetrahydro-6H-thiazolo[5,4-d]azepine, ihre Herstellung und ihre Verwendung als Arzneimittel.
ES468125A1 (es) Procedimiento para la preparacion de 42,3-dihidro-2,2 - di- metilbenzofuran-7-il-n-metil-carbamoil-) -(n'-alquilcarba- moil)-sulfuros
ZA874385B (en) Hydroxypyrazole derivatives,their preparation and their use against microorganism
ES8207541A1 (es) Procedimiento para la preparacion de derivados de pirimidina
FI961246A0 (fi) Radiofarmaseutika preparationer av radiojoderade bentsodiatsepinanaloger och deras anvaendning i diaknostik
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3363261D1 (en) Use of 5-phenyl-1,4-benzodiazepines for the manufacture of analgesic pharmaceutical compositions
JPS57108087A (en) (4,5)-4h-benzo(1,2-b)cycloheptafuran derivative, manufacture and use as medicine
DE3564685D1 (en) 1-oxadethiacephalosporin derivatives and processes for their preparation
ES8200890A1 (es) Procedimiento para preparar benzodiazepinas
IL82419A0 (en) 3-amino-dihydropyridines,their preparation and medicaments containing them
ES2007745A6 (es) Proceddimiento de preparacion de nuevos derivados triazoles ciclicos condensados.
ES8301991A1 (es) Procedimiento para la preparacion de 7-(2,6-dibromo-4-metil-fenil)-2,3-dihidro-imidazo 1,2-a, imidazoles.